Financial value

Laying a firm foundation for your laboratory’s financial future

To patients waiting for a diagnosis, laboratory profitability is likely the last thing on their mind. However, ensuring that the “business of care” is running smoothly is vital to getting that person the result they need within an appropriate timeframe. Successfully managing a laboratory is complex, and healthy financial performance is just one part of the equation.

An often-downplayed part of a laboratory’s success is reputation. Ensuring patient safety through quality assured analytical processes, timely delivery of results, complying with evolving regulatory standards, and managing risk are all factors that contribute to public perception. How can laboratories factor reputation management into their long-term financial planning in an industry rife with change?

Want to know more?

Get exclusive insights and information from real labs

Embracing a sustainable approach to change


Laboratories are facing increasing pressure to do more with less, and the Molecular Work Area can help make that a reality. The “more” we refer to is not just about throughput or capacity—it is about people and the value laboratories can provide to the broader health system. A sufficiently trained, competent, and motivated team has the potential to change a business, and that is worth investing in.

New levels of automation will free-up staff to perform higher value tasks, raising morale in the process.

Recent studies have shown that job satisfaction among lab staff is strongly influenced by perceived levels of autonomy, flexibility and professional development.1,2 Significant reductions in manual workloads3 will allow laboratories to achieve short-term efficiency KPIs, while also developing staff for future opportunities. For example, laboratories in Spain and Denmark are leveraging new data capabilities and time-liberated staff to extend the reach of their services.

True consolidation will minimize the number of instruments required to run the tests needed to meet demand. 

A large commercial laboratory group successfully decreased their footprint and created growth potential, moving from 15 analyzers to just 3 cobas® 8800 Systems. When they consolidated their hepatitis C viral load testing onto the new systems, they saw an overall improvement in result quality and an increase in capacity of 30-40%.4

Integrated solutions uncover new efficiencies by streamlining testing and creating seamless workflows.

The Molecular Work Area can automate greater than 90% of non-urgent, routine molecular testing. This creates the potential for significant operational cost savings. For example, when Roche Healthcare Consultants evaluated the expected impact of Roche’s solution for a medium-size lab in Sweden, they estimated a savings of 1.55 M SEK. Once implemented, the measured impact was 1.44 M SEK, demonstrating a predictive accuracy of 94.5%.4

Standardized processes can minimize the number of workflows for technicians, potentially reducing human error.

The cobas® 5800, 6800 and 8800 Systems fully automate molecular testing, including sample prep, real-time PCR amplification, detection, analysis and interpretation of results. Automated result interpretation leverages a thoroughly tested algorithm verified against more than 400,000 growth curves for true consistency and confidence.

Extend your value beyond diagnostics

Transforming your laboratory with the Molecular Work Area can elevate the support you provide to clinicians, empowering them to make better-informed decisions and allowing your staff, your business, and your reputation to flourish.

  1. Alrawahi S, Sellgren S, Alwahaibi N, Altouby S, Brommels M. Factors affecting job satisfaction among medical laboratory technologists in University Hospital,Oman: An exploratory study. Int J Health Plann Mgmt. 2019;34:e763–e775.
  2. University of Bath. Overlooked Voices: The Relationship Between Job-demands, Satisfaction and Commitment of NHS Scientists and Technicians. Accessed 17 June, 2020.
  3. Data on file with Roche.
  4. Data on file with Roche.